# Phase Ib Trial of Two Folate Binding Protein Peptide Vaccines (E39 and J65) in Breast and Ovarian Cancer Patients

> **NCT02019524** · PHASE1 · COMPLETED · sponsor: **COL George Peoples, MD, FACS** · enrollment: 39 (actual)

## Conditions studied

- Breast Cancer
- Ovarian Cancer

## Interventions

- **BIOLOGICAL:** E39 peptide vaccine
- **BIOLOGICAL:** E39 vaccine then J65 vaccine
- **BIOLOGICAL:** J65 vaccine then E39 vaccine

## Key facts

- **NCT ID:** NCT02019524
- **Lead sponsor:** COL George Peoples, MD, FACS
- **Sponsor class:** FED
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-09-30
- **Primary completion:** 2016-12-06
- **Final completion:** 2016-12-06
- **Target enrollment:** 39 (ACTUAL)
- **Last updated:** 2020-03-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02019524

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02019524, "Phase Ib Trial of Two Folate Binding Protein Peptide Vaccines (E39 and J65) in Breast and Ovarian Cancer Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02019524. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*